Charidimou Andreas, Boulouis Gregoire, Roongpiboonsopit Duangnapa, Auriel Eitan, Pasi Marco, Haley Kellen, van Etten Ellis S, Martinez-Ramirez Sergi, Ayres Alison, Vashkevich Anastasia, Schwab Kristin M, Goldstein Joshua N, Rosand Jonathan, Viswanathan Anand, Greenberg Steven M, Gurol M Edip
From the Hemorrhagic Stroke Research Program, Department of Neurology, Stroke Research Center (A.C., G.B., D.R., E.A., M.P., K.H., E.S.v.E., S.M.-R., A.A., A. Vashkevich, K.M.S., J.N.G., J.R., A. Viswanathan, S.M.G., M.E.G.), and Division of Neurocritical Care and Emergency Neurology (J.N.G., J.R.), Massachusetts General Hospital, Harvard Medical School, Boston; and Department of Neurology (E.A.), Carmel Medical Center, Haifa, Israel.
Neurology. 2017 Nov 21;89(21):2128-2135. doi: 10.1212/WNL.0000000000004665. Epub 2017 Oct 25.
In order to explore the mechanisms of cortical superficial siderosis (cSS) multifocality and its clinical implications for recurrent intracerebral hemorrhage (ICH) risk in patients with cerebral amyloid angiopathy (CAA), we used a new rating method that we developed specifically to evaluate cSS extent at spatially separated foci.
Consecutive patients with CAA-related ICH according to Boston criteria from a single-center prospective cohort were analyzed. The new score that assesses cSS multifocality (total range 0-4) showed excellent interrater reliability (k = 0.87). The association of cSS with markers of CAA and acute ICH was investigated. Patients were followed prospectively for recurrent symptomatic ICH.
The cohort included 313 patients with CAA. Multifocal cSS prevalence was 21.1%. ε2 allele prevalence was higher in patients with multifocal cSS. In probable/definite CAA, cSS multifocality was independently associated with neuroimaging markers of CAA severity, including lobar microbleeds, but not with acute ICH features, which conversely, were determinants of cSS in possible CAA. During a median follow-up of 2.6 years (interquartile range 0.9-5.1 years), the annual ICH recurrence rates per cSS scores (0-4) were 5%, 6.5%, 13.5%, 16.2%, and 26.9%, respectively. cSS multifocality (presence and spread) was the only independent predictor of increased symptomatic ICH risk (hazard ratio 3.19; 95% confidence interval 1.77-5.75; < 0.0001).
The multifocality of cSS correlates with disease severity in probable CAA; therefore cSS is likely to be caused by discrete hemorrhagic foci. The new cSS scoring system might be valuable for clinicians in determining annual risk of ICH recurrence.
为了探究皮质表面铁沉积症(cSS)多灶性的机制及其对脑淀粉样血管病(CAA)患者复发性脑出血(ICH)风险的临床意义,我们采用了一种专门开发的新评分方法来评估空间上分离病灶处的cSS程度。
对来自单中心前瞻性队列、符合波士顿标准的CAA相关ICH连续患者进行分析。评估cSS多灶性的新评分(总分范围0 - 4)显示出极好的评分者间信度(k = 0.87)。研究了cSS与CAA标志物及急性ICH的关联。对患者进行前瞻性随访以观察复发性症状性ICH情况。
该队列包括313例CAA患者。多灶性cSS患病率为21.1%。多灶性cSS患者中ε2等位基因患病率更高。在可能/确诊的CAA中,cSS多灶性与CAA严重程度的神经影像学标志物独立相关,包括脑叶微出血,但与急性ICH特征无关,相反,急性ICH特征是可能CAA中cSS的决定因素。在中位随访2.6年(四分位间距0.9 - 5.1年)期间,cSS评分(0 - 4)对应的每年ICH复发率分别为5%、6.5%、13.5%、16.2%和26.9%。cSS多灶性(存在及范围)是症状性ICH风险增加的唯一独立预测因素(风险比3.19;95%置信区间1.77 - 5.75;P < 0.0001)。
cSS的多灶性与可能CAA中的疾病严重程度相关;因此cSS可能由离散的出血灶引起。新的cSS评分系统可能对临床医生确定ICH每年复发风险有价值。